MedTrace Logo

Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension

NCT03211767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2019-02-12

No results posted yet for this study

Summary

The primary objective of this trial is to assess the effect of consumption of aged garlic extract powder on 24 h systolic and diastolic ambulatory blood pressure in hypertensive individuals following 8 weeks of supplementation.

Additional secondary objectives are to assess the effects of aged garlic extract powder intake for 8 weeks on lipid profile (TC, HDL-C, LDL-C, and TG concentrations), blood glucose, office blood pressure, pulse-wave velocity and augmentation index, body mass index, and waist and hip circumference.

Conditions

Interventions

DIETARY_SUPPLEMENT

Aged garlic extract

Each capsule contains 600mg of aged garlic extract powder

DIETARY_SUPPLEMENT

Placebo

Each capsule contains cellulose as a filler.

Sponsors & Collaborators

  • Wakunga of America Co. Ltd.

    collaborator UNKNOWN

  • Purity Life Health Products LP

    collaborator UNKNOWN

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Peter Jones, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2018-07-25
Completion
2018-07-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211767 on ClinicalTrials.gov